North, Central and South American IVD Market Opportunities & Gaps, 2018-2025

NEXT STORY
Entasis Therapeutics Announces Multiple Data Presentations at ECCMID 2019
PREV STORY
CB2 Insights Completes Acquisition of Cannabis Evaluation Clinics in Arizona and Colorado
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ChemioCare Formed to Transform Chemo-Induced Emesis Outcomes Through Patch Technology

NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare”) today announced ...

author_avatar
NASDAQ Market News

GLPG1690-resultaten in IPF in The Lancet Respiratory Medicine en gepresenteerd op ATS

Mechelen, België; 20 mei 2018; 20.30 uur CET; Galapagos NV (Euronext & NASDAQ: GLPG) ...

author_avatar
NASDAQ Market News

Orion and Bayer have completed the phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer – The primary endpoint was met

ORION CORPORATION        STOCK EXCHANGE RELEASE         24  OCTOBER 2018 AT  8.30  a.m. EEST Orion and ...

author_avatar
NASDAQ Market News